From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

Publisher： Karger

E-ISSN： 1421-9751|117|3|163-173

ISSN： 0008-6312

Source： Cardiology, Vol.117, Iss.3, 2010-11, pp. : 163-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 14-20

Karger

Access to resources Recommend Favorite

Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Protocol

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 3, 2015-04 ,pp. : 452-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 29-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction

By  

Cardiology, Vol. 137, Iss. 2, 2017-04 ,pp. : 121-125

Karger

Access to resources Recommend Favorite